Hospitalizations, nursing home admissions, and deaths attributable to diabetes

Diabetes Care

Volumn 28, Issue 7, 2005, Pages 1611-1617

  Russell, Louise B ^a   Valiyeva, Elmira ^a,b,c   Roman, Sheila H ^d   Pogach, Leonard M ^e   Suh, Dong Churl ^b,c   Safford, Monika M ^f  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGING; DEATH; DIABETES MELLITUS; DISEASE COURSE; FEMALE; HEALTH CARE COST; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INSTITUTIONALIZATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; NURSING HOME; PREVALENCE; PRIMARY PREVENTION; REVIEW; RISK FACTOR; SIMULATION;

AGED; ALCOHOL DRINKING; BODY WEIGHT; CHRONIC DISEASE; COMPUTER SIMULATION; DIABETES MELLITUS; DIET; HEALTH SURVEYS; HOSPITALIZATION; HUMANS; MIDDLE AGED; NURSING HOMES; PATIENT ADMISSION; RISK FACTORS; UNITED STATES;

EID: 21544460165     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.7.1611     Document Type: Review

References (26)

1. American Diabetes Association: Screening for type 2 diabetes (Position Statement). Diabetes Care 27 (Suppl. 1):S11-S14, 2004
2. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229-234, 1998
3. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
4. UK Prospective Diabetes Study (UKPDS) Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 317:703-713, 1998
5. Heart Outcomes Prevention Evaluation Study Investigators: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICROHOPE substudy. Lancet 355:253-259, 2000
6. The LIFE Study Group: Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359:1004-1010, 2002
7. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348:383-393, 2003
8. Collins R, Armitage J, Parish S, Sleigh P, Peto R, the Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361:2005-2016, 2003
9. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
10. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, Willett WC: Diet, lifestyle, and risk of type 2 diabetes mellitus in women. N Engl J Med 345:790-797, 2001
11. Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002
12. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M, the Finnish Diabetes Prevention Study Group: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350, 2001
13. Gordis L: Epidemiology. Philadelphia, WB Saunders Company, 2000
14. Lilienfeld DE, Stolley PD: Foundations of Epidemiology, 3rd ed. New York, Oxford, 1994
15. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
16. Russell LB, Carson JL, Taylor WC, Milan E, Dey A, Jagannathan R: Modeling all-cause mortality: estimates of the impact of smoking cessation based on the NHEFS. Am J Public Health 88:630-636, 1998
17. Russell LB, Teutsch SM, Kumar R, Dey A, Milan E: Preventable smoking and exercise-related hospital admissions: a model based on the NHEFS. Am J Prev Med 20: 26-34, 2001
18. Russell LB, Valiyeva E, Carson JL: Effects of prehypertension on admissions and deaths: a simulation. Arch intern Med 164: 2119-2124, 2004
19. Brandle M, Zhou H, Smith BR, Marriott D, Burke R, Tabaei BP, Brown MB, Herman WH: The direct medical cost of type 2 diabetes. Diabetes Care 26:2300-2304, 2003
20. Selby JV, Ray GT, Zhang D, Colby CJ: Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care 20:1396-1402, 1997
21. Brown JB, Nichols GA, Glauber HS, Bakst AW: Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis. Diabetes Care 22:1116-1124, 1999
22. O'Brien JA, Shomphe LA, Kavanagh PL, Raggio G, Caro JJ: Direct medical costs of complications resulting from type 2 diabetes in the US. Diabetes Care 21:1122-1128, 1998
23. Brown JB, Pedula KL, Bakst AW: The progressive cost of complications in type 2 diabetes mellitus. Arch Intern Med 159: 1873-1880, 1999
24. Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, Wagner EH: Patient-level estimates of the cost of complications in diabetes in a managed care population. Pharmacoecon 16:285-295, 1999
25. American Diabetes Association: Economic costs of diabetes in the U.S. in 2002. Diabetes Care 26:917-932, 2003
26. Hall MJ, Owings MF: 2000 National Hospital Discharge Survey. In Advance Data From Vital and Health Statistics, no. 329. Hyattsville, MD, National Center for Health Statistics, 2002